FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to a pharmaceutical composition for phosphate adsorption in a body and/or from biological fluids when administered orally or externally, and to a biologically active food additive. The pharmaceutical composition and the biologically active food additive contains a physical mixture or a combination of powders, granules, crystals or chips of calcium, magnesium or iron salts in a certain mole relation of Ca2+, Mg2+ and Fe3+. The concentration of Ca+2 is 80 mg - 2,400 mg; the concentration of Mg+ is 49 mg - 729 mg and the concentration of Fe+3 is 112 mg - 1,676 mg in a daily dose.
EFFECT: invention provides effective binding of phosphate in a wide range of pH levels causing no overdosage of the consumed phosphate-binding compounds and enabling avoiding the related side effects.
20 cl, 10 dwg, 5 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FEED SUPPLEMENT IN TABLET FORM FOR CATS WITH CHRONIC KIDNEY INSUFFICIENCY | 2022 |
|
RU2802063C1 |
| PHOSPHATE ADSORBENT BASED ON IRON (III) COMPOUNDS AND CARBOHYDRATES | 2007 |
|
RU2447933C2 |
| ORAL COMPOSITION FOR PHOSPHOROUS COMPOUNDS ABSORPTION | 2005 |
|
RU2392926C2 |
| PHARMACEUTICALLY ACTIVE COMPOUNDS, THEIR OBTAINING, COMPOSITIONS CONTAINING THEM AND THEIR APPLICATION | 2006 |
|
RU2420297C2 |
| NICOTINAMIDE FOR TREATING DISLIPIDEMIA | 2018 |
|
RU2741426C1 |
| PHARMACEUTICAL COMPOSITION MYCEOSTIN STIMULATING SUPPORTING TISSUE AND ARTICULAR CARTILAGE REGENERATION (VERSIONS) | 2010 |
|
RU2444365C1 |
| METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC KIDNEY DISEASE | 2018 |
|
RU2764575C2 |
| LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS FOR THEREOF OBTAINING AND APPLICATION | 2011 |
|
RU2570007C2 |
| NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | 2014 |
|
RU2675364C2 |
| NHE3 BINDING COMPOUNDS AND METHODS FOR PHOSPHATE TRANSPORT INHIBITION | 2014 |
|
RU2786149C2 |
